@article{4e1343a98b444e9fb9f98f54921d9fae,
title = "Adaptive differentiation promotes intestinal villus recovery",
abstract = "Loss of differentiated cells to tissue damage is a hallmark of many diseases. In slow-turnover tissues, long-lived differentiated cells can re-enter the cell cycle or transdifferentiate to another cell type to promote repair. Here, we show that in a high-turnover tissue, severe damage to the differentiated compartment induces progenitors to transiently acquire a unique transcriptional and morphological postmitotic state. We highlight this in an acute villus injury model in the mouse intestine, where we identified a population of progenitor-derived cells that covered injured villi. These atrophy-induced villus epithelial cells (aVECs) were enriched for fetal markers but were differentiated and lineage committed. We further established a role for aVECs in maintaining barrier integrity through the activation of yes-associated protein (YAP). Notably, loss of YAP activity led to impaired villus regeneration. Thus, we define a key repair mechanism involving the activation of a fetal-like program during injury-induced differentiation, a process we term “adaptive differentiation.”",
keywords = "Hippo, YAP, adaptive differentiation, enteropathy, injury-repair, intestine, poly(I:C), regeneration, single-cell RNA sequencing, villus atrophy",
author = "Ohara, {Takahiro E.} and Marco Colonna and Thaddeus Stappenbeck",
note = "Funding Information: We acknowledge the following Washington University in St. Louis facilities: DDRCC, GTAC, Siteman Cancer Center Flow Cytometry Core, and Molecular Microbiology Imaging Facility. The Bill and Melinda Gates Foundation (OPP1098828, OPP1139330), Crohn's & Colitis Foundation, and National Institutes of Health (NIH) provided support. This work was funded by the following NIH grants: F30 DK120076 (T.E.O.); R01 DE025884, R01 AI134236, R01 DK124699, and R01 AI134035 (M.C.); R01 AT009741, R01 CA257523, and R01 DK122790 (T.S.S.). T.E.O. and T.S.S. designed the experiments and wrote the manuscript. T.E.O. performed the experiments, collected data, and analyzed the results. T.S.S. and M.C. supervised the study. The authors declare no competing interests. Funding Information: We acknowledge the following Washington University in St. Louis facilities: DDRCC, GTAC, Siteman Cancer Center Flow Cytometry Core, and Molecular Microbiology Imaging Facility. The Bill and Melinda Gates Foundation ( OPP1098828 , OPP1139330 ), Crohn{\textquoteright}s & Colitis Foundation , and National Institutes of Health (NIH) provided support. This work was funded by the following NIH grants: F30 DK120076 (T.E.O.); R01 DE025884 , R01 AI134236 , R01 DK124699 , and R01 AI134035 (M.C.); R01 AT009741 , R01 CA257523 , and R01 DK122790 (T.S.S.). Publisher Copyright: {\textcopyright} 2021",
year = "2022",
month = jan,
day = "24",
doi = "10.1016/j.devcel.2021.12.012",
language = "English",
volume = "57",
pages = "166--179.e6",
journal = "Developmental Cell",
issn = "1534-5807",
number = "2",
}